Department of Gastroenterology, Division of Medicine, Oslo University Hospital, Norway.
J Crohns Colitis. 2012 May;6(4):441-53. doi: 10.1016/j.crohns.2011.10.001. Epub 2011 Nov 9.
Data on the long-term effects of Crohn's disease (CD) on health-related quality of life (HRQoL) is scarce. We aimed to determine the HRQoL in CD patients 10 years after disease onset, to compare the results to the general population and to identify variables that could affect HRQoL.
CD patients from a population-based inception cohort (the IBSEN Study) met at a prescheduled ten-year follow-up. In addition to a structured interview, review of hospital records, clinical examination, laboratory tests and ileocolonoscopy, they completed a patient-reported questionnaire including the Short Form 36 (SF-36) and the Norwegian Inflammatory Bowel Disease Questionnaire (N-IBDQ). The SF-36 scores were compared to scores from the general population using one-sample t-tests. Standardized scores were calculated and interpreted according to Cohen's effect size index. The associations between relevant clinical and demographic factors and HRQoL were examined through linear regression analyses.
Ninety-nine patients completed the HRQoL questionnaires (response rate 86%). Median age 39 years, 42% women. Compared to the general population the patients reported significantly lower SF-36 scores on the general health and vitality dimensions. IBDQ total scores were in line with scores of patients in remission. Except for current symptom severity no clinical parameters affected HRQoL scores. Work status and sick leave affected HRQoL negatively.
In this chronic stage of CD, reduced general health and vitality scores need attention while reductions in disease specific HRQoL seem to be less predominant.
关于克罗恩病(CD)对健康相关生活质量(HRQoL)的长期影响的数据很少。我们旨在确定发病 10 年后 CD 患者的 HRQoL,并将结果与普通人群进行比较,并确定可能影响 HRQoL 的变量。
来自基于人群的发病队列(IBSEN 研究)的 CD 患者在预定的十年随访时参加。除了进行结构化访谈、查阅病历、临床检查、实验室检查和回结肠镜检查外,他们还完成了一份患者报告的问卷,包括简明健康状况量表 36 项(SF-36)和挪威炎症性肠病问卷(N-IBDQ)。使用单样本 t 检验将 SF-36 评分与普通人群的评分进行比较。根据 Cohen 的效应大小指数计算和解释标准化评分。通过线性回归分析检查相关临床和人口统计学因素与 HRQoL 之间的关联。
99 名患者完成了 HRQoL 问卷调查(应答率 86%)。中位年龄 39 岁,42%为女性。与普通人群相比,患者报告在一般健康和活力维度的 SF-36 评分明显较低。IBDQ 总分与缓解期患者的分数相符。除了当前症状严重程度外,没有临床参数影响 HRQoL 评分。工作状态和病假对 HRQoL 有负面影响。
在 CD 的这个慢性阶段,需要注意一般健康和活力评分的降低,而疾病特异性 HRQoL 的降低似乎不太明显。